A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The aim of this study is to evaluate the efficacy of depemokimab administered as an adjunctive therapy, in participants with Type 2 asthma at risk of exacerbations compared to the guideline recommended standard of care (SoC).
Epistemonikos ID: befe5fee682c1ee839aa3a243057e31a13ba72d3
First added on: Mar 07, 2026